SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-102259
Filing Date
2021-03-31
Accepted
2021-03-31 16:07:03
Documents
3
Period of Report
2021-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d129146d8k.htm 8-K 18667
2 EX-99.1 d129146dex991.htm EX-99.1 101909
3 GRAPHIC g129146g0329105240405.jpg GRAPHIC 3881
  Complete submission text file 0001193125-21-102259.txt   127284
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

IRS No.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39988 | Film No.: 21793322
SIC: 2834 Pharmaceutical Preparations